Compare non-dilutive grants (SBIR, ARPA-H, EU Horizon) with equity funding — dilution, timeline, and reporting burden.
Grants don't dilute you but they take 6-12 months, come with reporting overhead, and constrain what you can build. Equity is fast but permanent dilution.
Deep tech, biotech, climate, or dual-use defense. Applying for SBIR Phase I ($275K) or ARPA-H is worth the effort at pre-seed and seed.
Software, marketplaces, and consumer where speed matters more than dilution, and where the market rewards velocity.
Grants for R&D milestones, equity for commercialization. Non-dilutive capital de-risks the tech; equity funds go-to-market.
Investor directory · Fundraising library · Articles A–Z · Company funding database